Bei ya Immunotherapy (PD-1 / PD-L1 course) nje ya nchi (2026)
Immunotherapy (PD-1 / PD-L1 course) inagharimu kuanzia takriban $16,000 nchini India. Bei za kawaida za hospitali kutoka rekodi 72 za bei katika nchi 9. Chagua nchi ili kuona hospitali zake, madaktari na hatua za visa.
- Siku 14 kupona kabisa
- 9 nchi zilizolinganishwa
Bei hizi ni viwango vya bei za hospitali kutoka hifadhidata yetu, si bei ya mwisho. Jinsi tunavyothibitisha
Kadiria gharama yako yote
Chagua machaguo yako. Bei itabadilika papo hapo.
Kifurushi cha hospitali = kiwango cha bei ya kawaida kutoka bei za hospitali 8.
Machaguo ya chumba na kifaa (implant) yanatumia makadirio ya jumla (kad.). Chakula ni takriban $15 kwa mtu kwa siku. Nauli za ndege hazijajumuishwa.
Pata bei halisi 3 kwa makadirio hayaHospitali bora za Immunotherapy (PD-1 / PD-L1 course) kwa nchi
Jinsi tunavyopanga orodhaZimepangwa kwa uthibitisho, ukadiriaji wa wagonjwa na idadi ya maoni, kisha bei.
-
1 Indraprastha Apollo HospitalNew Delhi · India · ISO 9001 · JCI · NABH · ★ 4.9Kuanzia$8,860kuanzia $8,860 Madaktari 2 wameorodheshwa Imethibitishwa na JCI -
2 Bumrungrad InternationalBangkok · Thailand · HA · ISO 9001 · JCI · ★ 4.8Kuanzia$10,650kuanzia $10,650 Imethibitishwa na JCI -
3 Asan Medical CenterSeoul · South Korea · ISO 9001 · JCI · KOIHA · ★ 4.8Kuanzia$15,500kuanzia $15,500 Madaktari 21 wameorodheshwa Imethibitishwa na JCI -
4 Cleveland Clinic Abu DhabiAbu Dhabi · United Arab Emirates · DHA · DOH · JCI · ★ 4.7Kuanzia$21,560kuanzia $21,560 Imethibitishwa na JCI -
5 Mount Elizabeth HospitalSingapore · Singapore · ISO 9001 · JCI · ★ 4.7Kuanzia$24,660kuanzia $24,660 Imethibitishwa na JCI -
6 Acıbadem Maslak HospitalIstanbul · Turkey · ISO 9001 · JCI · ★ 4.6Kuanzia$13,260kuanzia $13,260 Imethibitishwa na JCI
Pata ripoti ya gharama na mipango ya Immunotherapy (PD-1 / PD-L1 course)
PDF ya bure iliyotayarishwa kwa bei zilizotangazwa leo. Ihifadhi, ichapishe au uwatumie familia yako kwenye WhatsApp.
Kilichomo ndani
- Bei kwa nchi, jiji na hospitali, zikilinganishwa na za nyumbani
- Bajeti kamili ya safari: matibabu, malazi, chakula, visa
- Ratiba ya siku kwa siku na hatua za kupona
- Muhtasari wa visa, orodha ya maandalizi na maswali ya kuuliza
- Matibabu (bei ya kawaida iliyotangazwa) 93% $16,000
- Malazi 4% $650
- Chakula 2% $400
- Usafiri wa ndani 1% $100
- Ada za visa 1% $150
- Jumla ya makadirio$17,300
Chanzo: medcasts.com · bei kufikia Mei 2026
Pata maoni ya pili bila malipo ndani ya saa 48.
Tuma picha za vipimo (scans) na taarifa zako. Mtaalamu mwandamizi atazipitia na kujibu kwa maandishi.
Madaktari bora wa upasuaji wa Immunotherapy (PD-1 / PD-L1 course)



Bei za Immunotherapy (PD-1 / PD-L1 course) kwa nchi
Bei ya kawaida ya hospitali kwa kila nchi, kutoka rekodi 72 za bei katika hifadhidata ya Medcasts.
Kawaida bei ya hospitali inajumuisha nini
- Daktari wa upasuaji, ganzi na chumba cha upasuaji
- Kukaa kwako hospitalini na huduma za wauguzi
- Vipimo vya kawaida na dawa wakati wa kukaa hospitalini
- Msaidizi wa Medcasts bila malipo, msaada wa barua ya visa na mipango ya kuchukuliwa uwanja wa ndege
- Havijajumuishwa: nauli za ndege na hoteli baada ya kutoka hospitalini
Kila bei tunayotuma inaonyesha kilichojumuishwa na kisichojumuishwa, mstari kwa mstari.
Mpango wako wa kupona
- Weeks 1–3Infusion days are short; mild fatigue, rash or itching may start.
- Weeks 4–12Immune side effects, such as diarrhoea, rash, cough or thyroid changes, may emerge and need prompt treatment.
- Months 3–6First response scans guide whether to continue; ongoing blood tests monitor organs.
- Months 6–24Treatment continues for the planned duration with regular scans, then surveillance.
Muda wa visa ya matibabu kwa kila nchi
Muda wa kushughulikia visa kwa kila nchi
Tunatuma barua ya mwaliko wa hospitali ndani ya saa 24 baada ya uamuzi wako. Angalia visa yako
Kuhusu Immunotherapy (PD-1 / PD-L1 course)
The drugs are antibodies, such as pembrolizumab or nivolumab, given as an infusion every few weeks, usually as an outpatient. Treatment may be used alone or with chemotherapy or other targeted drugs, and a test of PD-L1 or other biomarkers may guide the choice. Courses can last up to about two years, depending on the cancer and response.
Some people have deep and lasting responses, while others do not respond, so results depend on the cancer type, tumour biomarkers, previous treatment and general health. Because the immune system is activated, side effects can include inflammation of the skin, bowel, lungs, liver or hormone glands, which need prompt treatment. Scans every few months assess response.
Because infusions repeat, consider whether later doses can be given nearer home. If you travel, plan to remain close to the hospital for the first cycles and know the symptoms that need urgent attention. Bring biomarker reports and prior treatment records, and arrange regular blood and thyroid tests with your home oncologist.
Kwa kawaida inafaa kama
- A cancer type and stage for which PD-1 or PD-L1 drugs are approved or supported by evidence.
- Biomarker results, where relevant, that favour response.
- Able to attend scheduled infusions and report symptoms promptly.
Huenda ukahitaji kusubiri kama
- Active severe autoimmune disease, or an organ transplant, may be worsened by immunotherapy and needs specialist review.
- Needing high-dose steroids or immunosuppression may reduce effectiveness or raise risk.
- Active serious infection or poor organ function may need treatment first.
Jinsi ya kujiandaa
- Bring pathology, biomarker results such as PD-L1 or MSI status, and scans so the team can confirm eligibility.
- Expect baseline thyroid, liver, kidney and cortisol tests and a chest scan before starting.
- Tell your doctor about autoimmune disease, transplants, steroids or any immune-suppressing drugs.
- Carry a card describing your treatment, as emergency teams must know about immunotherapy.
- Plan how you will contact the hospital if side effects begin after you return home.
Maswali ya kumuuliza daktari wako wa upasuaji
- Which drug and schedule are recommended, and for how many cycles?
- Is my cancer type or biomarker result suitable for this treatment?
- Which immune side effects should I watch for and who do I call urgently?
- How will you judge response, and what happens if the scan looks worse at first?
- Can infusions be given nearer to home, and how are my records shared?
- What happens if I have to stop because of side effects?
Dalili za hatari unapolinganisha hospitali
- Treatment is offered without biomarker or pathology confirmation where these are needed.
- No emergency plan or contact for immune side effects, such as severe diarrhoea or breathlessness.
- Promises of cure, or use outside accepted indications without a clear explanation.
- No baseline thyroid, liver and kidney tests before starting.
Maswali kuhusu Immunotherapy (PD-1 / PD-L1 course) nje ya nchi
Ni nchi gani yenye bei nafuu zaidi kwa Immunotherapy (PD-1 / PD-L1 course)?
Bei za kawaida za hospitali za chini kabisa ziko India ($16,035), Thailand ($18,395), Uturuki ($22,015), kati ya nchi 9 tunazolinganisha.